204-226-2 | Sigma-Aldrich

Quality Control Ranges: MILLIPLEX® MAP Mouse Cytokine/Chemokine Panel

Control 2 570 - 1642 pg/mL M-CSF Control 1 98 - 204 pg/mL IL-15 Control 1 102 - 212 pg/mL RANTES Control 1 112 - 232 pg/mL Control 2 509 - 1056 pg/mL

Quality Control Ranges - Milliplex Mouse Cytokine/Chemokine Magnetic Panel

109 - 226 pg/mL Control 2 573 - 1190 pg/mL Control 2 500 - 1038 pg/mL Control 2 551 - 1144 pg/mL

Quality Control Range Sheet- A6042-104 and A6042-204

mL Control 2 1349 – 2802 pg/mL Control 2 493 – 1023 pg/mL IL-28A Control 1 226 – 469 pg/mL I-TAC Control 1

Data Sheet - P7957

pFLAG-1 241 to 264 pFLAG-2 181 to 204 pFLAG-MAC 200 to 223 pFLAG-ATS 260 to 283 pFLAG-CTC 200 to 223 pFLAG-CTS 255 to 278 pFLAG-SHIFT12 263 to 286 pFLAG-SHIFT12c 203 to 226 The C-24 Sequencing Primer

Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel

Control 1 109 - 226 pg/mL Control 2 536 - 1113 pg/mL Control 2 561 - 1165 pg/mL Eotaxin Control 1 99 -

XP725 Antibody Number-Lot Number 071M4826

266 267 268 3.2 197 198 199 200 221 222 223 224 245 246 247 248 269 270 271 272 3.3 201 202 203 204 225 226 227 228 249 250 251 252 273 274 275 276 3.4 205 206 207 208 229

Product Information Sheet - F3651

. 8. Rinderknecht, H., Experientia, 16, 430 (1960). 9. Xia, Z., et al., Br. J. Haematol., 93, 204-214 (1996). 10. Current Protocols in Immunol., Coligan, J.E. et al. (Eds.), pp. 5.3.3 (Wiley

Product Information Sheet - F4274

. 8. Rinderknecht, H., Experientia, 16, 430 (1960). 9. Xia, Z., et al., Br. J. Haematol., 93, 204-214 (1996). 10. Current Protocols in Immunol., Coligan, J.E. et al. (Eds.), pp. 5.3.3 (Wiley

Product Information Sheet - F4002

. 8. Rinderknecht, H., Experientia, 16, 430 (1960). 9. Xia, Z., et al., Br. J. Haematol., 93, 204-214 (1996). 10. Current Protocols in Immunol., Coligan, J.E. et al. (Eds.), pp. 5.3.3 (Wiley

Product Information Sheet - F7250

. 8. Rinderknecht, H., Experientia, 16, 430 (1960). 9. Xia, Z., et al., Br. J. Haematol., 93, 204-214 (1996). 10. Current Protocols in Immunol., Coligan, J.E. et al. (Eds.), pp. 5.3.3 (Wiley

Product Information Sheet - L6662

-109 2-Methyl-5-hydroxytryptamine maleate M-110 alpha-Methyl-5-hydroxytryptamine maleate M-137 Methysergide maleate M-149 Methiothepin mesylate M-153 Mesulergine hydrochloride M-204 p-MPPI

List of Antibodies

C3095 M y n/d n/d 202 Cytohesin-1 C8979 M y n/d n/d 203 Cytokeratin peptide 4 C5176 M y n/d n/d 204 Cytokeratin CK5 C7785 M y n/d n/d 205 Cytokeratin peptide 7 C6417 M y n/d n/d 206 Cytokeratin 8.12

User Guide Equinox SOP Software 2.1 for Windows XP

o seleccionar “File > Exit” en el menú principal. 204 — Instalación y configuración del programa informático y la bomba Capítulo 2 Guía rápida de la pantalla del usuario Este

XP725 Antibody List Lot 129K4831

_002265.2 ,NP_705694.2 y n/d n/d 209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y 204 Cytokeratin CK5 C7785 3875 KRT18 M NP_000215.1 ,NP_954657.1 y n/d n/d 210 Cytokeratin peptide 18 C1399

XP725 Antibody List Lot 129K4830

_002265.2 ,NP_705694.2 y n/d n/d 209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y 204 Cytokeratin CK5 C7785 3875 KRT18 M NP_000215.1 ,NP_954657.1 y n/d n/d 210 Cytokeratin peptide 18 C1399

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

Anti-PAK1 (Ser144)/PAK2 (Ser141), phospho-specific H WB APur Rb 100 µL AB3833 Anti-PAK1 (Ser199/204)/PAK2 (Ser192/197), H WB APur Rb 100 µL AB3834 phospho-specific Anti-PAK2, phospho-specific (

XP725 Antibody List Lot 089K4791

_002265.2 ,NP_705694.2 y n/d n/d 209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y 204 Cytokeratin CK5 C7785 3875 KRT18 M NP_000215.1 ,NP_954657.1 y n/d n/d 210 Cytokeratin peptide 18 C1399

Cytoskeletal Signaling Antibodies, Reagents and Kits

Anti-PAK1 (Ser144)/PAK2 (Ser141), H WB APur Rb 100 µL AB3833 phospho-specific Anti-PAK1 (Ser199/204)/PAK2 (Ser192/197), H WB APur Rb 100 µL AB3834 phospho-specific Anti-PAK2, phospho-specific (

XP725 Antibody List

9267 PSCD1 NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1 M y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7

XP725 Antibody List 013M4793

9267 PSCD1 NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1 M y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7

Halal Certificate

HC-23SI5Q33 201. 2-TRIDECANONE 96%, FG W338818 B20816 HC-23SIYW94 202. 2-TRIDECANONE NATURAL W338820 D12706 HC-23SIGY89 203. 2-UNDECANOL W324604 C49389 HC-23SIA242 204. 2-UNDECANONE 98%, FCC

Halal Certificate

HC-22SIIJ54 201. 2-TRIDECANONE 96%, FG W338818 B20816 HC-22SI8Y16 202. 2-TRIDECANONE NATURAL W338820 D12706 HC-22SIRJ11 203. 2-UNDECANOL W324604 C49389 HC-22SIBU63 204. 2-UNDECANONE 98%, FCC

XP725 Worksheet for Lot Number 071M4826

p 198 2 1 1 6 Caldesmon C6542 199 2 1 1 7 Calmodulin C7055 200 2 1 1 8 Calmodulin C7055 201 2 1 2 1 Calnexin C4731 202 2 1 2 2 Calnexin C4731 203 2 1 2 3 Calponin C2687 204 2

3D BIOPRINTING: Printing a Brighter Future

3D Bioprinting: Printing a Bright Future SigmaAldrich.com/matsci 15 spreading and proliferation.204–205 However, increasing the mesh size to enhance cell viability sacrifices mechanical properties.

3D BIOPRINTING: Printing a Brighter Future

3D Bioprinting: Printing a Bright Future SigmaAldrich.com/matsci 15 spreading and proliferation.204–205 However, increasing the mesh size to enhance cell viability sacrifices mechanical properties.